Abraham Ceesay, Chief Executive Officer at Rapport Therapeutics, sold RAPP on Jul 14, 2026
Data as of Oct 16
▼ SELL$218K5,481 shares at $39.72Abraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.
- Traded
- Jul 14, 2026
- Disclosed
- Jul 15, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
RAPP since disclosure
−31.0%
after the sale
Similar stocks (SPY) since disclosure
+1.1%
S&P 500 (SPY)
Change in closing price from Jul 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$111Kdisclosed Jul 15 · filed 1 day after the trade